Navigation Links
Innovations in Pediatric Medicine CME conference brings together national pediatrics experts
Date:10/14/2008

ll Cornell Medical College

8:00 8:45 a.m.
Newborn Screening for Inborn Errors of Metabolism
Dr. Piero Rinaldo, Mayo Clinic College of Medicine, Rochester, Minn.

8:45 9:15 a.m.
Prenatal Pediatrics: How Analysis of Fetal Nucleic Acids in Maternal Blood Provides Novel Opportunities to Improve Newborn Care
Dr. Diana W. Bianchi, Tufts University School of Medicine and the Floating Hospital for Children

9:15 9:45 a.m.
Early Diagnosis of Primary Immunodeficiencies
Dr. Jennifer M. Puck, University of California, San Francisco

10:15 10:45 a.m.
Current Status of Gene Therapy in Children
Dr. Alain Fischer, Descartes University Hospital NeckerEnfants Malades, Paris, France

10:45 11:15 a.m.
Molecular Physiology of the Control of Body Weight
Dr. Rudolph L. Leibel, Morgan Stanley Children's Hospital of NewYork-Presbyterian and Columbia University Medical Center

11:15 11:45 a.m.
Panel Discussion with Q&A

Plenary II
The Future of Stem Cell Therapy in Children

Moderator:
Dr. Mitchell Cairo, Morgan Stanley Children's Hospital of NewYork-Presbyterian and Columbia University Medical Center

12:30 1:15 p.m.
Stem Cell Therapeutics for Childhood Neurological Diseases
Dr. Evan Snyder, University of California, San Diego

1:15 1:45 p.m.
Prenatal Stem Cell Transplantation -- The Virtues of Tolerance
Dr. Alan W. Flake, Children's Hospital of Philadelphia and the University of Pennsylvania School of Medicine

1:45 2:15 p.m.
Applying Embryonic and Cord Blood Stem Cell Research to Children
Dr. Mervin C. Yoder, Indiana University School of Medicine

2:30 3:00 p.m.
Bioethical Challenges for Stem Cell Therapy in Children
Dr. Ruth L. Fischbach, Columbia University Medical Center

3:00 3:30 p.m.
Molecular Characterization of Normal and Leukemic Stem Cells
Dr. D
'/>"/>

Contact: Belinda Mager
bem9048@nyp.org
212-305-5587
New York- Presbyterian Hospital/Columbia University Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related biology news :

1. OHSU turns innovations into commercial opportunities at record pace
2. Synaptics SecurePad(TM) Selected as CES Innovations 2008 Design and Engineering Award Honoree
3. Sonic Innovations Celebrates 10-Year Anniversary
4. New chemical radar among national security innovations in ACS podcast
5. Improving industry efficiency through environmental innovations
6. Leading pediatrician addresses the future of childrens health
7. Pediatricians alerted to the developmental nature of underage drinking in special journal supplement
8. Immunotherapy in high-risk pediatric sarcomas shows promising response
9. Immune system protein accurate predictor of survival in pediatric septic shock
10. New research seeks to enhance quality and security of wireless telemedicine
11. Penn Veterinary Medicine report new strategy to create genetically-modified animals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... strengthen the evidence that people who smoke cigarettes over ... for developing colorectal cancer, even after adjusting for other ... not to smoke, or to quit as soon as ... vice president emeritus, epidemiology and surveillance research at the ...
(Date:12/2/2009)... cigarette smoking scenes in movies are more likely ... may be part of the acculturation process associated ... , "Our study supports an R-rating for smoking ... implementation of the World Health Organization Framework Convention ...
(Date:12/2/2009)... Smoky Mountain forest,s woodland herb population has shown that ... recover from logging, according to Purdue University research. , ... 80 years ago, the distribution of trillium plants on ... undisturbed areas. Michael Jenkins, a Purdue assistant professor of ...
Breaking Biology News(10 mins):Cigarette smoking increases colorectal cancer risk 2Watching movies featuring characters who smoke negatively influences Mexican-American teens 2Study finds logging effects vary based on a forest's history, climate 2University of Florida Shands Cancer Center Selects OnCore 28r 29 to Support its Collaborative Research Goals 13034 1University of Florida Shands Cancer Center Selects OnCore 28r 29 to Support its Collaborative Research Goals 13034 2University of Florida Shands Cancer Center Selects OnCore 28r 29 to Support its Collaborative Research Goals 13034 3University of Florida Shands Cancer Center Selects OnCore 28r 29 to Support its Collaborative Research Goals 13034 4University of Florida Shands Cancer Center Selects OnCore 28r 29 to Support its Collaborative Research Goals 13034 5MultiNational Underwriters Is Now HCC Medical Insurance Services 51740 1MultiNational Underwriters Is Now HCC Medical Insurance Services 51740 2 26quot 3BThe Safe 26quot 3B Way To Protect Against The Anguish Of Disaster Recovery 51736 1 26quot 3BThe Safe 26quot 3B Way To Protect Against The Anguish Of Disaster Recovery 51736 2 26quot 3BThe Safe 26quot 3B Way To Protect Against The Anguish Of Disaster Recovery 51736 3
... NY, November 18, 2008 -- Researchers at the University of ... have been used to block and reverse type 1 diabetes ... of the National Academy of Sciences , was led by ... and an expert in the field of autoimmunity. , "The ...
... LAFAYETTE, Ind. - Materials engineers have created a new ... if perfected, might be used for environmental cleanup, water ... last longer than conventional filters for separating oil from ... traits that are usually mutually exclusive. Researchers attached the ...
... German Research Foundation) is intensifying the international ... meeting in Bonn the Grants Committee responsible ... of 13 additional Research Training Groups, 7 ... These enable doctoral researchers to cooperate closely ...
Other Biology News:New filtering technology has environmental, industrial applications 2New filtering technology has environmental, industrial applications 3National and international doctoral training 2National and international doctoral training 3National and international doctoral training 4National and international doctoral training 5National and international doctoral training 6National and international doctoral training 7
(Date:12/2/2009)... NEW YORK, Dec. 2 Reportlinker.com announces ... available in its catalogue: ,, Neurostimulation ... http://www.reportlinker.com/p0164232/Neurostimulation---A-Global-Market-Perspective.html ,, The world ... base of aging population, and the resultant ...
(Date:12/2/2009)... Calif., Dec. 2 Peregrine Pharmaceuticals, Inc. (Nasdaq: ... a dose confirmation and dosimetry trial of Cotara® in ... of brain cancer. Cotara is a targeted monoclonal ... potential new treatment for GBM. Cotara specifically targets ...
(Date:12/2/2009)... Cell announced today,a feasibility study evaluating the preclinical ... product which combines technology from Weill,Cornell Medical College ... to,treat inherited anemias such as Cooley,s Anemia. , ... a series of technologies to expand, ex vivo,populations ...
(Date:12/2/2009)... The world is going through,extraordinary times; markets are in ... It turns out that the pharma industry has been,relatively ... a,vacation. , During the midst ... & Johnson inaugurated an R&D center in Shanghai, the ...
Breaking Biology Technology:Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3
... Dmitriy Ovcharenko, Rich Jarvis, , ... , ... experimental tool for reducing the expression of specific , ... function analysis, target , validation, ...
... Trace amounts of ribonuclease (RNase) , ... ubiquitous in the laboratory environment--on your skin, in the , ... bare hands or on anything left , ... or eliminate RNase contamination. However, determining which , ...
... , ... Cenix Pre-designed siRNAs to Human, Mouse, and Rat , ... Silencer Validated siRNAs , ... Superior siRNA Design Combined with High , Quality Custom RNA ...
Other Biology Technology:Delivering siRNAs to Difficult Cell Types 2Delivering siRNAs to Difficult Cell Types 3Delivering siRNAs to Difficult Cell Types 4Delivering siRNAs to Difficult Cell Types 5Delivering siRNAs to Difficult Cell Types 6Delivering siRNAs to Difficult Cell Types 7Combat RNase Contamination in the Lab 2Combat RNase Contamination in the Lab 3Combat RNase Contamination in the Lab 4Combat RNase Contamination in the Lab 5IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER! 2IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER! 3IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER! 4IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER! 5IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER! 6IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER! 7IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER! 8IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER! 9IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER! 10
One unit is equal to 10Kb (insert DNA + vector). The final cost will increase or decrease according to the final assembled genome size. The price does not include genome annotation....
Nuclear/Cytosol Fractionation Kit Research Focus: other Storage Temperature: 4C Shipping Temperature: 4C...
Peptide-affinity Purified Polyclonal Antibody to MTR...
Polyclonal Antibody to AGAP1 / Centaurin, gamma 2...
Biology Products: